Novel Targets of Chemotherapeutic Drugs that Trap Protein on DNA
Novel Targets of Chemotherapeutic Drugs that Trap Protein on DNA
批准号:
8878499
负责人:
Nancy Maizels
金额:
$16.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-03-10 至 2017-02-28
关键词:
Adverse effectsAzacitidineBinding ProteinsBiochemicalBiologicalBreast CarcinomaCell physiologyCellsClinicClinicalClinical TrialsColorectal CancerComplexDNADNA AdductsDNA Modification MethylasesDNA TopoisomerasesDecitabineDoseDoxorubicinDrug TargetingDrug effect disorderDrug usageEffectivenessEtoposideFundingFutureGenesGoalsLeadMalignant NeoplasmsMalignant neoplasm of cervix uteriMethodsMutateMutationNucleic AcidsPharmaceutical PreparationsPoisonProteinsProteomicsRNARNA BindingSmall Interfering RNASolid NeoplasmSpecificitySpliceosomesTOP1 geneTOP2A geneTestingTopoisomeraseValidationadductcovalent bonddrug mechanismdrug sensitivityhuman DNAimprovedinsightirinotecanmRNA Exportnew therapeutic targetnovelnovel strategiespublic health relevanceresearch studysmall moleculesuccesstooltumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Some very potent chemotherapeutics used in the clinic function by stabilizing covalent protein-DNA adducts formed as obligatory intermediates in normal cellular function. Despite the demonstrated effectiveness of these drugs, there has been no effort to systematically identify all targets of drugs in this class. Our proposal describes a novel approach that combines stringent enrichment of covalent protein adducts upon drug treatment with unbiased proteomics to identify and discover drug targets. Using this approach, we have confirmed known targets of topotecan and etoposide, and we have identified novel targets of these drugs, thereby establishing the power of this approach as a discovery tool. We propose to apply this approach to identify the targets of six chemotherapeutic drugs that function by this mechanism: etoposide, doxorubicin, topotecan, decitabine (5-aza-dC), azacitidine (5-aza-C) and olaparib, and to validate these targets. Success in these experiments will identify new targets of drugs in current use, and establish a general approach for determining mechanisms of drug action to enable future identification of novel drug-target pairs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism-based targeting of bacterial topoisomerases
-
批准号:9243114
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2016
-
负责人:Nancy Maizels
-
依托单位:
Novel Targets of Chemotherapeutic Drugs that Trap Protein on DNA
-
批准号:9031087
-
项目类别:
-
资助金额:$20.16万
-
财政年份:2015
-
负责人:Nancy Maizels
-
依托单位:
Mechanisms of loss of heterozygosity in cancer
-
批准号:8989522
-
项目类别:
-
资助金额:$20.16万
-
财政年份:2014
-
负责人:Nancy Maizels
-
依托单位:
Mechanisms of loss of heterozygosity in cancer
-
批准号:8805324
-
项目类别:
-
资助金额:$16.8万
-
财政年份:2014
-
负责人:Nancy Maizels
-
依托单位:
Genomic Instability at DNA Nicks
-
批准号:8815606
-
项目类别:
-
资助金额:$31.35万
-
财政年份:2014
-
负责人:Nancy Maizels
-
依托单位:
Genomic Instability at DNA Nicks
-
批准号:9111836
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2014
-
负责人:Nancy Maizels
-
依托单位:
Genomic Instability at DNA Nicks
-
批准号:9324162
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2014
-
负责人:Nancy Maizels
-
依托单位:
Molecular Medicine Training Program
-
批准号:8500375
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2011
-
负责人:Nancy Maizels
-
依托单位:
A Novel Platform for Rapid Development for Anti-WNV Antibodies
-
批准号:8301089
-
项目类别:
-
资助金额:$43.3万
-
财政年份:2011
-
负责人:Nancy Maizels
-
依托单位:
Chemosensitivity and DNA Repair
-
批准号:8277944
-
项目类别:
-
资助金额:$27.02万
-
财政年份:2011
-
负责人:Nancy Maizels
-
依托单位:
Molecular Medicine Training Program
-
批准号:8877564
-
项目类别:
-
资助金额:$10.03万
-
财政年份:2011
-
负责人:Nancy Maizels
-
依托单位:
Molecular Medicine Training Program
-
批准号:8286169
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2011
-
负责人:Nancy Maizels
-
依托单位:
Molecular Medicine Training Program
-
批准号:8017171
-
项目类别:
-
资助金额:$7.41万
-
财政年份:2011
-
负责人:Nancy Maizels
-
依托单位:
Molecular Medicine Training Program
-
批准号:9148320
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2011
-
负责人:Nancy Maizels
-
依托单位:
Chemosensitivity and DNA Repair
-
批准号:7747268
-
项目类别:
-
资助金额:$27.28万
-
财政年份:2009
-
负责人:Nancy Maizels
-
依托单位:
Targeted Gene Repair by Homologous Recombination (Component 8 of 11)
-
批准号:7904470
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2009
-
负责人:Nancy Maizels
-
依托单位:
Mutagenesis 2008 Gordon Research Conference
-
批准号:7481663
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2008
-
负责人:Nancy Maizels
-
依托单位:
Mutagenesis 2008 Gordon Research Conference
-
批准号:7660377
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2008
-
负责人:Nancy Maizels
-
依托单位:
Mutagenesis 2008 Gordon Research Conference
-
批准号:8473173
-
项目类别:
-
资助金额:$0.2万
-
财政年份:2008
-
负责人:Nancy Maizels
-
依托单位:
Mutagenesis 2008 Gordon Research Conference
-
批准号:8128620
-
项目类别:
-
资助金额:$0.2万
-
财政年份:2008
-
负责人:Nancy Maizels
-
依托单位:
国内基金
海外基金
CRISPR/Cas9全基因组文库筛选Venetoclax/Azacitidine耐药关键基因及其机制研究
-
批准号:82100198
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:胡甜园
-
依托单位: